Clozapine augmented with aripiprazole in 5 patients with schizophrenia [4]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 6, 2006, Pages 669-671

  Abu Tair, Fatima ^a   Kopitz, Jürgen ^a   Bergemann, Niels ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHLORPROTHIXENE; CLOZAPINE; DIAZEPAM; FLUPENTIXOL; IMIPRAMINE; LAMOTRIGINE; METIXENE; OXCARBAZEPINE; PANTOPRAZOLE; VALPROIC ACID;

BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE REGIMEN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LINEAR REGRESSION ANALYSIS; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SOLID PHASE EXTRACTION; STEADY STATE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33751119908     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000246206.65411.f5     Document Type: Letter

References (11)

1. Bergemann N, Kopitz J, Kress KR, et al. Plasma amisulpride levels in schizophrenia and schizoaffective disorder. Eur Neuropsychopharmacol. 2004;14:245-250.
2. Freudenreich O, Goff DC. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risk of current combinations. Acta Psychiatr Scand. 2002;106:323-330.
3. Frick A, Kopitz J, Bergemann N. Clozapin erhöht den Amisulprid-Plasmaspiegel. Psychopharmakotherapie. 2003;10:28-31.
4. Josiassen RC, Joseph A, Kohegyi E, et al. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2005;162:130-136.
5. Lerner V, Libov I, Kotler M, et al. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:89-98.
6. Ziegenbein M, Sieberer M, Calliess I. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia. Aust NZ J Psychiatry. 2005;39:840-841.
7. Ziegenbein M, Kropp S, Künzel HE. Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study. Clin Neuropharmacol. 2005;28:220-224.
8. Fitzsimons J, Berk M, Lambert T, et al. A review of clozapine safety. Expert Opin Drug Saf. 2005;4:731-744.
9. Gupta S, Masand P. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry. 2004;16:155-166.
10. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
11. Weigmann H, Hiemke C. Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection. J Chromatogr. 1992;583:209-216.